Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Switzerland Health Monitor.
Bio Usawa Biotechnology and Bioeq AG Partner to Create Widespread Access to Vision-Saving Medicine Across Sub-Saharan Africa
GlobeNewswire, Inc.
·
July 1, 2025
KIGALI, Rwanda and SAN FRANCISCO and ZUG, Switzerland , July 01, 2025 (GLOBE NEWSWIRE) -- Bio Usawa Biotechnology Ltd. (Bio Usawa) and Bioeq AG today announced a groundbreaking agreement that will bring a life-changing biosimilar...
Alvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia® (certolizumab pegol)
GlobeNewswire, Inc.
·
July 1, 2025
REYKJAVIK, Iceland and LONDON, July 01, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco Limited...
ONWARD Medical Files 510(k) with US FDA for ARC-EX System Home Use and Submits CE Mark Application
GlobeNewswire, Inc.
·
July 1, 2025
FDA 510(k) application submitted to allow marketing of the ARC-EX® System for home use in the United States CE Mark application filed with notified body to enable commercialization of the ARC-EX System in the European Union and other countries...
AsedaSciences® and Euretos Partner to Integrate Platforms for Deeper Insights from Disease Biology to Drug Discovery
EIN Presswire
·
June 30, 2025
Unified AI-powered platforms will link hundreds of data sources to deliver unprecedented, high-resolution insights into disease, targets, compounds, and safety SCHINDELLEGI, SCHWYZ, SWITZERLAND, June 30, 2025 /EINPresswire.com/ -- AsedaSciences,...
Gain Therapeutics Announces Completion of Target Enrollment in Phase 1b Clinical Study Evaluating GT-02287 in People With Parkinson’s Disease With or Without a GBA1 Mutation
GlobeNewswire, Inc.
·
June 30, 2025
As of June 30th, 16 participants have enrolled in the Phase 1b, ahead of the original goal of at least 15 total participants by 3Q 2025 Analysis of 90-day biomarker activity from cerebrospinal fluid (CSF) in all participants currently enrolled is...
Stalicla Secures CHF 2 Million Financing Led by Addex Therapeutics to Advance Precision Medicine Neurodevelopmental Disorder Programs
GlobeNewswire, Inc.
·
June 30, 2025
Press Release Stalicla Secures CHF 2 Million Financing Led by Addex Therapeutics to Advance Precision Medicine Neurodevelopmental Disorder Programs Geneva, Switzerland – June 30, 2025 – STALICLA SA, a Geneva-based clinical-stage biotech company...
Addex Leads CHF 2 Million Investment in Stalicla to Advance Precision Medicine in Neuropsychiatric Disorders
GlobeNewswire, Inc.
·
June 30, 2025
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland – June 30, 2025 – Addex Therapeutics (SIX: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for...
Medical Professional Liability Insurance Market Forecasted to Reach $33.7 Billion by 2031, Says Allied Market Research
EIN Presswire
·
June 26, 2025
Medical Professional Liability Insurance Market Forecasted to Reach $33.7 Billion by 2031, Says Allied Market Research NEW CASTLE, DE, UNITED STATES, June 27, 2025 /EINPresswire.com/ -- According to the report published by Allied Market...
New ABB circuit breaker to make AI data centers and advanced manufacturing more resilient
GlobeNewswire, Inc.
·
July 1, 2025
ZURICH, July 01, 2025 (GLOBE NEWSWIRE) -- The new SACE Emax 3 air circuit breaker will improve energy security and resilience of power systems in critical infrastructure – including data centers, factories, hospitals, and airports Cutting-edge...
Pharvaris Announces Clinical Trial Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at the 2025 US HAEA National Summit
GlobeNewswire, Inc.
·
June 27, 2025
ZUG, Switzerland, June 27, 2025 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated...
Orphalan Partners with MAP International and the Wilson Disease Association to Provide Life-Changing Medicine to Underserved Communities
GlobeNewswire, Inc.
·
June 27, 2025
FOR IMMEDIATE RELEASE Orphalan Partners with MAP International and the Wilson Disease Association to Provide Life-Changing Medicine to Underserved Communities Paris, France —27, June, 2025— Orphalan SA, a global pharmaceutical company focused on...
Cleveland Clinic and MeCo Diagnostics publish first-ever study of mechanical conditioning in circulating tumor cells
EIN Presswire
·
June 26, 2025
Pioneering study bolsters rationale for targeted antifibrotic therapy in early breast cancer, reaffirming drug repositioning strategies across pharma SAN DIEGO, CA, UNITED STATES, June 26, 2025 /EINPresswire.com/ -- A multinational breast cancer...
Landmark report spotlights Switzerland’s rise as a global leader in Deep Tech where startups are driving $100B in value
GlobeNewswire, Inc.
·
June 26, 2025
Zurich, June 26, 2025 (GLOBE NEWSWIRE) -- While global attention has often centered on innovation hubs such as Silicon Valley, Berlin, or Paris, today, fresh data from Dealroom.co and Startupticker in a new report spotlights how Switzerland has...
Europe IV Hydration Therapy Market Set to Witness Significant Growth by 2025-2032: Sechoir, ELIXIR, Swiss Medical Centre
EIN Presswire
·
June 26, 2025
BURLINGAME, CA, UNITED STATES, June 26, 2025 /EINPresswire.com/ -- The Europe IV Hydration Therapy industry is undergoing rapid expansion, driven by growing awareness of wellness and preventive healthcare. Increasing adoption across sports...
SEALSQ Strengthens IoMT Security and Edge AI Integration with Post-Quantum Technology to Safeguard Next-Generation Healthcare Systems
GlobeNewswire, Inc.
·
June 26, 2025
Geneva, Switzerland, June 26, 2025 (GLOBE NEWSWIRE) -- SEALSQ’s unique value proposition integrates PKI with Quantum-Resistant Cryptography and Post-Quantum Secure Hardware SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses...
Sandoz further asserts leadership in biosimilars, breaking ground on new Slovenia facility to expand European biosimilar hub and global market reach
GlobeNewswire, Inc.
·
July 1, 2025
MEDIA RELEASE Investment marks latest step in strategic plan to capture significant part of unprecedented biosimilar patent-expiry market opportunity of USD 222 billion over next 10 years Ongoing investment in in-house manufacturing to create...
DIH Appoints Rehazentrum Valens as a DIH Center of Excellence
GlobeNewswire, Inc.
·
July 1, 2025
NORWELL, Mass., and ZÜRICH, Switzerland, July 01, 2025 (GLOBE NEWSWIRE) -- DIH HOLDING US, Inc. (“DIH”) (NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive...
SEALSQ and WISeKey Launch the Quantum Corridor: A New Era of Cross-Border DeepTech Innovation
GlobeNewswire, Inc.
·
July 1, 2025
Geneva, Switzerland, July 01, 2025 (GLOBE NEWSWIRE) -- Quantum Corridor connects next-generation quantum, AI, cybersecurity, and semiconductor projects across Spain, France, Switzerland, and the United States SEALSQ Corp (NASDAQ: LAES) ("SEALSQ"...
ReproNovo Announces First Participant Included in U.S. Phase 2 Trial of RPN-001 for Male Infertility
GlobeNewswire, Inc.
·
July 1, 2025
RPN-001 is a novel orally administered aromatase inhibitor being developed for the treatment of infertility in men with low serum testosterone No FDA-approved oral therapies currently exist for this underserved population LAUSANNE, Switzerland and...
Balfour Capital Group Welcomes Salvatore Napolitano: Senior Advisor
EIN Presswire
·
July 1, 2025
Hedge Funds, Investments, Trading YVERDON-LES-BAINS, SWITZERLAND, July 1, 2025 /EINPresswire.com/ -- Balfour Capital Group, a leading global boutique investment firm, is pleased to announce the appointment of Salvatore Napolitano as Senior...